Back to search
Ann Arbor Stage III Grade 1 Follicular Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ann Arbor Stage III Grade 1 Follicular Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ann Arbor Stage III Grade 1 Follicular Lymphoma trials you may qualify forThis phase II trial tests the safety, side effects and effectiveness of mosunetuzumab in treating patients with slow growing (indolent) B-cell lymphoma. Mosunet…
This is a single center, open label, single arm phase II clinical trial. The objective of this study is to assess the feasibility and efficacy of zanubrutinib c…
This phase II trial studies how well acalabrutinib, lenalidomide, and rituximab work in treating patients with CD20 positive stage III-IV, grade 1-3a follicular…
This phase I trial studies the side effects and best dose of lenalidomide and ibrutinib when given together with rituximab in treating patients with previously…